Terms: = Breast cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68 AND Prognosis
8 results:
1. AURKAIP1 actuates tumor progression through stabilizing ddx5 in triple negative breast cancer.
Tian W; Tang Y; Luo Y; Xie J; Zheng S; Zou Y; Huang X; Wu L; Zhang J; Sun Y; Tang H; Du W; Li X; Xie X
Cell Death Dis; 2023 Dec; 14(12):790. PubMed ID: 38040691
[TBL] [Abstract] [Full Text] [Related]
2. Wnt Signaling Pathway Collapse upon β-Catenin Destruction by a Novel Antimicrobial Peptide SKACP003: Unveiling the Molecular Mechanism and Genetic Activities Using breast cancer Cell Lines.
Selvarathinam K; Subramani P; Thekkumalai M; Vilwanathan R; Selvarajan R; Abia ALK
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770598
[TBL] [Abstract] [Full Text] [Related]
3. Upregulated expression of ddx5 predicts recurrence and poor prognosis in breast cancer.
Li K; Zhao G; Yuan H; Zhang J; Li Q; Gong D; Lin P
Pathol Res Pract; 2022 Jan; 229():153736. PubMed ID: 34923193
[TBL] [Abstract] [Full Text] [Related]
4. Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer.
Tan Y; Sun R; Liu L; Yang D; Xiang Q; Li L; Tang J; Qiu Z; Peng W; Wang Y; Ye L; Ren G; Xiang T
Theranostics; 2021; 11(11):5214-5231. PubMed ID: 33859743
[No Abstract] [Full Text] [Related]
5. Transcriptomics and prognosis Analysis to Identify Critical Biomarkers in Invasive breast Carcinoma.
Wu J; Liu XJ; Hu JN; Liao XH; Lin FF
Technol Cancer Res Treat; 2020; 19():1533033820957011. PubMed ID: 33176622
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
[TBL] [Abstract] [Full Text] [Related]
7. The RNA helicase/transcriptional co-regulator, p68 (ddx5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers.
Iyer RS; Nicol SM; Quinlan PR; Thompson AM; Meek DW; Fuller-Pace FV
Cell Cycle; 2014; 13(9):1413-23. PubMed ID: 24626184
[TBL] [Abstract] [Full Text] [Related]
8. Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer.
Dutertre M; Gratadou L; Dardenne E; Germann S; Samaan S; Lidereau R; Driouch K; de la Grange P; Auboeuf D
Cancer Res; 2010 May; 70(9):3760-70. PubMed ID: 20406972
[TBL] [Abstract] [Full Text] [Related]
